Benign prostatic hyperplasia.
Doherty
Alan P
AP
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017292:Doxazosin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D004791:Enzyme Inhibitors; D011799:Quinazolines; D018120:Finasteride; C047638:alfuzosin; D017292:Doxazosin